Results 1 to 10 of about 8,553 (204)

AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH‐suppressed autophagy

open access: goldCancer Science, 2023
AKR7A3 is a member of the aldo‐keto reductase (AKR) protein family, whose primary purpose is to reduce aldehydes and ketones to generate primary and secondary alcohols. It has been reported that AKR7A3 is downregulated in pancreatic cancer (PC). However,
Lei Hua   +14 more
semanticscholar   +2 more sources

Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof-of-concept clinical study. [PDF]

open access: yesEpilepsia
Abstract Objective Drug‐resistant epilepsy (DRE) affects >25 million people worldwide and is often associated with neuroinflammation. Increasing evidence links deficiency or malfunctioning of the enzyme phosphoglycerate dehydrogenase (PHGDH), which converts 3‐phosphoglycerate to generate serine and the neurotransmitter glycine, with (drug‐resistant ...
Thevissen K   +25 more
europepmc   +2 more sources

Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling [PDF]

open access: hybridCellular & Molecular Immunology
Phosphoglycerate dehydrogenase (PHGDH) has emerged as a crucial factor in macromolecule synthesis, neutralizing oxidative stress, and regulating methylation reactions in cancer cells, lymphocytes, and endothelial cells.
Zhengnan Cai   +8 more
semanticscholar   +2 more sources

Integrative metabolome and transcriptome analyses provide insights into PHGDH in colon cancer organoids. [PDF]

open access: yesBiosci Rep
As a rate-limiting enzyme in the endogenous serine de novo synthesis pathway, 3-Phosphoglycerate dehydrogenase (PHGDH) has been widely concerned about its role in a variety of tumors including colon cancer and the development of inhibitors.
Chen L   +8 more
europepmc   +2 more sources

Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism and mTORC1 signaling.

open access: greenAmerican Journal of Physiology. Endocrinology and Metabolism, 2023
Cells use glycolytic intermediates for anabolism e.g., via the serine synthesis and pentose phosphate pathways. However, we still understand poorly how these metabolic pathways contribute to skeletal muscle cell biomass generation.
Sakari Mäntyselkä   +10 more
semanticscholar   +3 more sources

PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability. [PDF]

open access: yesCancer Res
Overexpression of PHGDH, the rate-limiting enzyme in the serine synthesis pathway, promotes melanomagenesis, melanoma cell proliferation, and survival of metastases in serine-low environments such as the brain.
Jasani N   +8 more
europepmc   +2 more sources

Identification of novel PHGDH inhibitors based on computational investigation: an all-in-one combination strategy to develop potential anti-cancer candidates

open access: goldFrontiers in Pharmacology
Objective Biological studies have elucidated that phosphoglycerate dehydrogenase (PHGDH) is the rate-limiting enzyme in the serine synthesis pathway in humans that is abnormally expressed in numerous cancers.
Yujing Xu   +5 more
semanticscholar   +2 more sources

CLN5 deficiency impairs glucose uptake and uncovers PHGDH as a potential biomarker in Batten disease. [PDF]

open access: hybridMol Psychiatry
Marchese M   +14 more
europepmc   +3 more sources

PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma

open access: yesNature Communications, 2023
The role of protein arginine methylation in serine metabolism of cancer cells in hepatocellular carcinoma (HCC) remains to be explored. Here, the authors show that phosphoglycerate dehydrogenase (PHGDH) is activated by PRMT1-mediated R236 methylation ...
Kui Wang   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy